Prudential Financial Inc. Increases Stock Holdings in Diversified Healthcare Trust (NASDAQ:DHC)

Prudential Financial Inc. lifted its holdings in shares of Diversified Healthcare Trust (NASDAQ:DHC - Free Report) by 15.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,804,078 shares of the real estate investment trust's stock after acquiring an additional 241,400 shares during the quarter. Prudential Financial Inc. owned 0.75% of Diversified Healthcare Trust worth $4,149,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. RBF Capital LLC grew its stake in Diversified Healthcare Trust by 433.1% in the 3rd quarter. RBF Capital LLC now owns 1,300,000 shares of the real estate investment trust's stock valued at $5,447,000 after purchasing an additional 1,056,131 shares during the period. Anson Funds Management LP purchased a new position in shares of Diversified Healthcare Trust in the 3rd quarter worth about $2,995,000. Jacobs Levy Equity Management Inc. bought a new position in Diversified Healthcare Trust during the third quarter valued at about $2,197,000. Cibc World Markets Corp purchased a new stake in Diversified Healthcare Trust during the fourth quarter worth about $990,000. Finally, JPMorgan Chase & Co. raised its position in Diversified Healthcare Trust by 60.3% in the third quarter. JPMorgan Chase & Co. now owns 863,806 shares of the real estate investment trust's stock worth $3,619,000 after acquiring an additional 324,787 shares during the period. 75.98% of the stock is owned by hedge funds and other institutional investors.

Diversified Healthcare Trust Stock Performance

NASDAQ:DHC traded down $0.14 on Thursday, reaching $2.31. 620,944 shares of the company's stock were exchanged, compared to its average volume of 980,312. The firm has a market cap of $557.26 million, a price-to-earnings ratio of -1.43 and a beta of 2.02. The company has a debt-to-equity ratio of 1.44, a current ratio of 11.57 and a quick ratio of 11.57. The stock has a fifty day simple moving average of $2.56 and a 200-day simple moving average of $2.77. Diversified Healthcare Trust has a 52 week low of $2.01 and a 52 week high of $4.24.

Remove Ads

Diversified Healthcare Trust (NASDAQ:DHC - Get Free Report) last announced its quarterly earnings results on Tuesday, February 25th. The real estate investment trust reported $0.02 EPS for the quarter, beating analysts' consensus estimates of ($0.29) by $0.31. Diversified Healthcare Trust had a negative net margin of 26.09% and a negative return on equity of 17.55%. The company had revenue of $379.62 million for the quarter, compared to analysts' expectations of $370.97 million.

Diversified Healthcare Trust Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, February 20th. Stockholders of record on Monday, January 27th were issued a $0.01 dividend. This represents a $0.04 dividend on an annualized basis and a dividend yield of 1.73%. The ex-dividend date was Monday, January 27th. Diversified Healthcare Trust's payout ratio is currently -2.60%.

Analysts Set New Price Targets

DHC has been the subject of a number of research reports. StockNews.com raised shares of Diversified Healthcare Trust from a "sell" rating to a "hold" rating in a research report on Tuesday. B. Riley began coverage on Diversified Healthcare Trust in a report on Thursday. They set a "buy" rating and a $4.50 price objective for the company.

Diversified Healthcare Trust Company Profile

Diversified Healthcare Trust is a real estate investment trust, which engages in the ownership of senior living communities, medical office buildings, and wellness centers. It operates through the following segments: Office Portfolio, Senior Housing Operating Portfolio (SHOP), and Non-Segment. The Office Portfolio segment consists of medical office properties leased to medical providers and other medical related businesses, as well as life science properties leased to biotech laboratories and other similar tenants.